Laser Photonics Announces Closing of $7.9 Million Public Offering

Laser Photonics completes a $7.9 million stock and warrant financing to fund R&D, potential acquisitions, and working capital.

Rhea-AI Summary

Laser Photonics (LASE) closed a public offering on September 14, 2026, raising approximately $7.9 million in gross proceeds.

The offering consisted of 10,500,000 shares of common stock, Series B-1 warrants to purchase up to 10,500,000 shares, and Series B-2 warrants to purchase up to 10,500,000 shares, all sold at a combined public offering price of $0.75 per share and accompanying warrants. Both warrant series carry an exercise price of $0.75 per share and are exercisable upon issuance, with the Series B-1 warrants expiring five years from issuance and the Series B-2 warrants expiring twenty-four months from issuance. H.C. Wainwright & Co. acted as exclusive placement agent.

The company plans to use net proceeds for research and development of its laser-based technologies, acquisitions, and working capital. The securities were offered under an effective Form S-1 registration statement.

Positive

• Gross proceeds of ~$7.9 million from the offering before fees and expenses
• Sale of 10,500,000 shares at a combined price of $0.75 with attached warrants
• Warrants exercisable at $0.75 could provide additional capital if exercised
• Stated use of proceeds includes R&D, acquisitions, and working capital

Negative

• Issuance of 10,500,000 new shares dilutes existing shareholders
• Additional overhang from 21,000,000 new warrants (Series B-1 and B-2) on the common stock

News Explained

The completed financing adds 10,500,000 common shares and leaves two immediately exercisable warrant pools that could add more.

The offering closed on September 14, 2026, issuing 10,500,000 common shares; absent offsetting changes, that reduces existing common holders' percentage ownership.

The two warrant series are exercisable upon issuance and each covers up to 10,500,000 additional common shares, so exercise would create a further potential reduction in existing holders' percentage ownership.

The offering's $7.9 million gross proceeds equal 248.5 days of the last reported quarterly operating cash use, based on the supplied calculation.

At June 30, 2026, reported cash and investments equaled 77.3 days of that quarterly operating cash use, based on the supplied calculation.

The September 14, 2026 final prospectus is the named filing to check for net proceeds after placement fees and other offering expenses, which the release does not quantify.

Sources and calculations

• Laser Photonics Announces Closing of $7.9 Million Public Offering (2026-09-15)
• Dilution (2026-07-17)
• Laser Photonics second-quarter 2026 fundamentals (2026Q2)
• Laser Photonics 424B4 prospectus (2026-09-14)

• Offering gross against the last reported quarterly operating outflow, in days at that rate $7,900,000 / ($2,892,882 / 91) = 248.5 days
• Available liquidity against the last reported quarterly operating outflow, in days at that rate ($2,156,631 + $302,000) / ($2,892,882 / 91) = 77.3 days

Key Figures

Common shares offered: 10,500,000 shares Offering price: $0.75 per share Series B-1 warrants: 10,500,000 warrants +5 more

Common shares offered

10,500,000 shares

Public offering closing

Offering price

$0.75 per share

Combined with accompanying warrants

Series B-1 warrants

10,500,000 warrants

Exercisable at $0.75 per share

Series B-2 warrants

10,500,000 warrants

Exercisable at $0.75 per share

Warrant exercise price

$0.75 per share

Warrants exercisable upon issuance

Series B-1 expiration

Five years

From the date of issuance

Series B-2 expiration

Twenty-four months

From the date of issuance

Gross proceeds

$7.9 million

Before placement agent fees and offering expenses

Previous Offering Reports

1 past event · Latest: Sep 10

Same Type 1 event

1. Sep 10

   Public offering pricing

   24h Move

   -2.1%

   Pricing of the same public offering established its share-and-warrant terms before closing.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

warrants, exercise price, placement agent, registration statement, +1 more

5 terms

warrants financial

"Series B-1 warrants to purchase up to 10,500,000 shares"

Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

View in glossary

exercise price financial

"The warrants have an exercise price of $0.75 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

placement agent financial

"acted as the exclusive placement agent for the offering"

A placement agent is a professional or firm that helps organizations raise money from investors, such as individuals, institutions, or funds. They act like matchmakers, connecting those seeking investments with the right investors and guiding the process to ensure successful funding. For investors, they can provide access to exclusive opportunities and help navigate complex fundraising efforts.

registration statement regulatory

"A registration statement on Form S-1"

A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.

form s-1 regulatory

"registration statement on Form S-1"

A Form S-1 is the registration filing a company submits to the U.S. Securities and Exchange Commission when it plans to offer stock to the public, most commonly for an initial public offering. Think of it as the company’s full disclosure packet or blueprint: it contains audited financials, business description, management background, risk factors and details of the offering, giving investors the information needed to judge the company’s financial health and potential risks before buying shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ORLANDO, FL / ACCESS Newswire / September 15, 2026 / Laser Photonics Corporation (NASDAQ:LASE) (the "Company"), a developer of laser systems for industrial and defense applications, today announced that it closed its previously announced public offering on September 14, 2026 of 10,500,000 shares of common stock, Series B-1 warrants to purchase up to 10,500,000 shares of common stock and Series B-2 warrants to purchase up to 10,500,000 shares of common stock, at a combined public offering price of $0.75 per share and accompanying warrants. The warrants have an exercise price of $0.75 per share and are exercisable upon issuance. The Series B-1 warrants will expire five years from the date of issuance and the Series B-2 warrants will expire twenty-four months from the date of issuance.

H.C. Wainwright & Co., LLC acted as the exclusive placement agent for the offering.

The gross proceeds to the Company from the offering were approximately $7.9 million, before deducting the placement agent's fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from this offering for research and development for the Company's various laser-based technologies, acquisitions and working capital.

A registration statement on Form S-1 (File No. 333-298783) relating to the offering was declared effective by the Securities and Exchange Commission (the "SEC") on September 10, 2026. The offering was made only by means of a prospectus forming part of the effective registration statement relating to the offering. A final prospectus relating to the offering has been filed with the SEC. Electronic copies of the final prospectus may be obtained on the SEC's website at https://www.sec.gov and may also be obtained by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by phone at (212) 856-5711 or e-mail at placements@hcwco.com.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

About Laser Photonics Corporation

Laser Photonics Corporation (NASDAQ:LASE) is a developer of laser systems for industrial and defense applications. The Company develops and manufactures advanced laser technologies used in cleaning, surface preparation, and precision material processing across demanding operating environments. Laser Photonics serves a broad range of end markets, including defense and government, aerospace, energy, maritime, automotive, and advanced manufacturing. Through a combination of internal development, strategic acquisitions, and partnerships, the Company continues to expand its product portfolio and address new applications where performance, efficiency, and environmental considerations are critical. For more information, please visit laserphotonics.com.

Cautionary Note Concerning Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable securities laws, including, without limitation, statements regarding the intended use of net proceeds from the offering. These statements are based on current expectations as of the date of this press release and involve risks and uncertainties that may cause results and uses of proceeds to differ materially from those indicated by these forward-looking statements. We encourage readers to review the "Risk Factors" in our Registration Statement and other filings with the SEC for a comprehensive understanding. Laser Photonics Corp. undertakes no obligation to revise or update any forward-looking statements, except as required by applicable laws or regulations, to reflect events or circumstances after the date of this press release.

Investor Relations Contact

Lucas A. Zimmerman & Ian Scargill
MZ Group - MZ North America
(262) 357-2918
LASE@mzgroup.us
www.mzgroup.us

SOURCE: Laser Photonics Corp.

View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What securities were included in Laser Photonics' public offering and at what price?

The offering included 10,500,000 shares of common stock, Series B-1 warrants to purchase up to 10,500,000 shares, and Series B-2 warrants to purchase up to 10,500,000 shares. They were sold at a combined public offering price of $0.75 per share and accompanying warrants.

What are the key terms of the Series B-1 and Series B-2 warrants?

Both the Series B-1 and Series B-2 warrants have an exercise price of $0.75 per share and are exercisable upon issuance. The Series B-1 warrants expire five years from the date of issuance, while the Series B-2 warrants expire twenty-four months from the date of issuance.

How does Laser Photonics intend to use the net proceeds from the offering?

The company intends to use the net proceeds for research and development for its various laser-based technologies, for acquisitions, and for working capital.

Who acted as placement agent for the offering and how can investors obtain the final prospectus?

H.C. Wainwright & Co., LLC acted as the exclusive placement agent. Electronic copies of the final prospectus are available on the SEC's website at https://www.sec.gov. It may also be obtained from H.C. Wainwright & Co., LLC, 430 Park Avenue, 3rd Floor, New York, NY 10022, by phone at (212) 856-5711 or by e-mail at placements@hcwco.com.

Under what registration statement was this offering conducted and when was it declared effective?

The securities were offered under a registration statement on Form S-1 (File No. 333-298783), which was declared effective by the SEC on September 10, 2026.